Capstone Investment Advisors
KYNB

Capstone Investment Advisors’s Kyntra Bio KYNB Stock Holding History

Capstone Investment Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-276
Closed -$327K – 412
2017
Q4 		$327K Buy
+276
New +$346K 0.01% 350

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Capstone Investment Advisors's KYNB Position: Q1 2018 in Review

Capstone Investment Advisors sold out of Kyntra Bio (KYNB) in Q1 2018, closing a stake of 276 shares — an estimated $327K sold.

Capstone Investment Advisors first reported a position in KYNB in Q4 2017 and held it in 1 quarter. The position peaked at $327K in Q4 2017. 193 funds tracked by Wall St. Rank hold KYNB as of Q1 2018.

  • Capstone Investment Advisors reported no remaining Kyntra Bio position as of Q1 2018 after selling out during the quarter.
  • Capstone Investment Advisors sold 276 Kyntra Bio shares in Q1 2018, an estimated $327K.
  • Capstone Investment Advisors first reported a position in Kyntra Bio in Q4 2017 and held it in 1 quarter.
  • Capstone Investment Advisors's Kyntra Bio position peaked at $327K in Q4 2017.
  • 193 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2018.

Based on Capstone Investment Advisors's 13F filing for Q1 2018, filed 15 May 2018.